Level Bio AB (publ) (NGM:LEVBIO)
0.3300
-0.0240 (-6.78%)
At close: Mar 19, 2026
Level Bio AB Market Cap
Level Bio AB has a market cap or net worth of 22.57 million as of March 20, 2026. Its market cap has increased by 19.57% in one year.
Market Cap
22.57M
Enterprise Value
20.09M
Revenue
32.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.33
Market Cap Chart
Since September 18, 2006, Level Bio AB's market cap has decreased from 35.14M to 22.57M, a decrease of -35.77%. That is a compound annual growth rate of -2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 22.57M | 10.00% |
| Dec 30, 2025 | 20.52M | 8.70% |
| Dec 30, 2024 | 18.88M | -27.02% |
| Dec 29, 2023 | 25.87M | -45.31% |
| Dec 30, 2022 | 47.30M | -70.97% |
| Dec 30, 2021 | 162.94M | 142.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qbrick AB | 28.22M |
| Spermosens AB | 27.91M |
| LightAir AB | 27.86M |
| Goobit Group AB | 27.72M |
| Relevance Communication Nordic AB | 27.33M |
| JonDeTech Sensors AB | 25.60M |
| Transiro Holding AB | 25.12M |
| Vaxxa AB | 24.63M |